Skip to main content
. 2016 May 4;3(1):e000184. doi: 10.1136/openhrt-2014-000184

Table 4.

Characteristics of asymptomatic versus symptomatic patients (mean±SD unless otherwise stated)

Controls Aortic
stenosis
Mitral
stenosis
Aortic
regurgitation
Mitral
regurgitation
Number of subjects NYHA 1 39 17 16 32 16
NYHA 2 17 14 7 17
Total 39 34 30 39 33
BNP (pg/mL) NYHA 1 26.8±13.0 33.7±19.3 60.2±45.9 40.9±37.7 33.6±19.4
NYHA 2 45.0±24.8 86.1±50.4 74.2±75.9 52.3±29.7
p Value 0.19 0.08 0.10 0.04
Severe valve disease, n (%) NYHA 1 2 (12) 1 (6) 19 (58) 13 (81)
NYHA 2 6 (35) 4 (29) 5 (71) 8 (47)
p Value 0.22 0.16 0.69 0.04
LV end-diastolic volume index (mL/m2) NYHA 1 52.3±12.7 52.8±14.4 46.9±9.6 90.3±28.6 80.5±11.2
NYHA 2 46.6±18.1 39.4±11.8 95.7±29.5 72.9±15.6
p Value 0.28 0.07 0.57 0.12
LV end-systolic volume index (mL/m2) NYHA 1 19.0±7.1 18.7±7.6 17.9±6.1 33.3±13.7 28.3±6.4
NYHA 2 22.8±15.4 14.9±5.4 36.7±16.8 25.6±6.5
p Value 0.61 0.18 0.50 0.61
LV ejection fraction (%) NYHA 1 65±8 63±8 62±9 64±6.2 65±7
NYHA 2 61±6 63±4 63±7 65±6
p Value 0.32 0.86 0.80 0.96
LA area index (cm2/m2) NYHA 1 10.6±1.9 11.5±2.5 18.2±6.0 10.6±2.0 17.4±3.9
  NYHA 2 11.4±2.6 20.5±5.9 11.8±2.0 17.6±5.0
p Value 0.90 0.16 0.14 0.73
Pulmonary artery pressure (mm Hg) NYHA 1 25±4 30±7 32±14 28±6 32±6
NYHA 2 35±6 40±8 31±9 42±16
p Value 0.06 0.01 0.19 0.03
Valve area index/EROA index (cm2/m2) NYHA 1 0.51±0.09 0.71±0.15 0.11±0.07 0.38±0.16
NYHA 2 0.45±0.14 0.62±0.16 0.16±0.07 0.29±0.15
p Value 0.15 0.13 0.06 0.10
Exercise capacity (METS) NYHA 1 12.6±3.1 10.9±2.8 7.0±3.0 11.3±3.6 11.1±1.6
NYHA 2 7.4±2.5 5.5±2.0 9.4±1.9 7.2±2.1
p Value 0.003 0.19 0.26 <0.0001

BNP, brain natriuretic peptide; EROA, effective regurgitant orifice area; LA, left atrium; LV, left ventricle; NYHA, New York Heart Association.